Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP Uptake and Adherence in Young South African Women (3P)
NCT03142256Phase 4Unknown
- Sponsor
- Desmond Tutu HIV Centre
- Start
- Mar 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Desmond Tutu HIV Centre. Status: unknown.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03142256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142256.